Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • CXC chemokines: Potential biom...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

Show other versions (1)
Bibliographic Details
Published in:PLoS ONE
Main Authors: Guang Wang, Juan Fu, Mulin Liu, Qin Zheng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI

Similar Items

  • CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
    by: Guang Wang, et al.
    Published: (2024-01-01)
  • Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
    by: Weina Kong, et al.
    Published: (2021-07-01)
  • CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
    by: Xuezhi Zhou, et al.
    Published: (2021-03-01)
  • FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
    by: N. V. Kipich, et al.
    Published: (2014-07-01)
  • Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
    by: Tesfaye Wolde, et al.
    Published: (2024-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs